Press Releases

GI Dynamics to Present Data from Clinical Weight Loss Study of EndoBarrier™ Gastrointestinal Liner in Morbidly Obese Patients at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress

(IFSO) 13th World Congress LEXINGTON, Mass., September 19, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to...

read more

GI Dynamics Announces Data Demonstrating Immediate and Sustained Reduction in HbA1c in Patients with Type 2 Diabetes Using EndoBarrier™ Gastrointestinal Liner

Compelling Clinical Data Highlighted at First World Congress on Interventional Therapies for Type 2 Diabetes Show Improved Glycemic Control and Weight Reduction in Uncontrolled Diabetics NEW YORK, NY, September 16, 2008 – GI Dynamics, a medical device company pioneering the development of new...

read more

Data from Clinical Trial of EndoBarrier™ Gastrointestinal Liner in Patients with Type 2 Diabetes to be Presented at the First World Congress on Interventional Therapies for Type 2 Diabetes in New York

LEXINGTON, Mass., September 9, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to treat obesity and type 2...

read more
Page 18 of 18« First...10...1415161718